ClinicalTrials.gov
ClinicalTrials.gov Menu

Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01127750
Recruitment Status : Completed
First Posted : May 21, 2010
Last Update Posted : February 23, 2017
Sponsor:
Information provided by (Responsible Party):
Novartis